$0.9193
-0.0607-6.19%
Last update: Oct 23, 9:16 AM
NeuroOne Medical Technologies Corp (NMTC) Stock Price, Quote, News & History
NMTCNASDAQ
NeuroOne submits FDA filing early for trigeminal nerve ablation using its OneRF system as the facial pain market sees projected growth to $416 million by 2030.
You can purchase shares of NeuroOne Medical Tech (NASDAQ:NMTC) through any online brokerage.
Other companies in NeuroOne Medical Tech’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
NeuroOne Medical Tech has a consensus price target of $7.33.
The stock price for NeuroOne Medical Tech (NASDAQ: NMTC) is $0.9589 last updated October 23, 2026 at 9:16 AM EDT.
There are no upcoming dividends for NeuroOne Medical Tech.
NeuroOne Medical Tech does not have any upcoming earnings scheduled.
There is no upcoming split for NeuroOne Medical Tech.
NeuroOne Medical Tech is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.
NeuroOne Medical Technologies Corp is focused on diagnostic, ablation, and deep brain stimulation technology for brain-related conditions such as epilepsy and Parkinson's disease; ablation and stimulation for pain management; and drug delivery with...
